Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypersensitivity Reactions: Cytolytic Reactions01:01

Hypersensitivity Reactions: Cytolytic Reactions

140
Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
140
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

2.9K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.9K
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

15.8K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
15.8K
Hemoglobin01:24

Hemoglobin

10.1K
Hemoglobin is a globular protein made up of four subunits. Two of these subunits are alpha chains, and the other two are beta chains. Each subunit contains a molecule of heme, which has an iron atom and can bind to oxygen. When an oxygen molecule binds to one heme group, it changes the shape of hemoglobin, making it easier for the other heme groups to bind oxygen as well.
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
10.1K
Hypoxia01:23

Hypoxia

2.6K
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
2.6K
Lifecycle of Erythrocytes01:22

Lifecycle of Erythrocytes

6.1K
Erythrocytes, also known as red blood cells, constantly move through blood capillaries. As a result, they damage their plasma membrane due to the continuous friction. Typically, after 100 to 120 days, erythrocytes become rigid and fragile as they wear out. As they pass through small vessels in the spleen and liver, they can get trapped and break apart into fragments.
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups....
6.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient-Reported Outcomes After Ferric Carboxymaltose Treatment for Iron Deficiency Anemia: A Prospective Observational Study.

International journal of general medicine·2023
Same author

The Impact of an Antithrombotic Stewardship Program on Heparin-Induced Thrombocytopenia Management.

Journal of pharmacy practice·2022
Same author

Ocular involvement in TEMPI syndrome.

American journal of ophthalmology case reports·2022
Same author

Current challenges of hematologic complications due to immune checkpoint blockade: a comprehensive review.

Annals of hematology·2021
Same author

Systems controls are needed to reduce mistaken tests for hemophagocytic lymphohistiocytosis, results of a prospective quality-improvement cohort study.

Medicine·2021
Same author

Newer formulations of intravenous iron: a review of their chemistry and key safety aspects - hypersensitivity, hypophosphatemia, and cardiovascular safety.

Expert opinion on drug safety·2021

Related Experiment Video

Updated: Apr 11, 2026

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
06:29

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells

Published on: January 29, 2014

31.4K

Paroxysmal cold hemoglobinuria.

Satish Shanbhag1, Jerry Spivak1

  • 1Division of Hematology, Department of Medicine, The Johns Hopkins University School of Medicine, Suite 4500, 301 building 4940 Eastern Ave, Baltimore, MD 21224, USA.

Hematology/Oncology Clinics of North America
|June 5, 2015
PubMed
Summary
This summary is machine-generated.

Paroxysmal cold hemoglobinuria (PCH) is a rare autoimmune hemolytic anemia. This complement-mediated condition involves a P antigen antibody, causing red blood cell destruction, particularly in cold conditions.

Keywords:
Autoimmune hemolytic anemiaCoombs negative hemolysisDonath-LandsteinerPCHSyphilis

More Related Videos

Induction of Eryptosis in Red Blood Cells Using a Calcium Ionophore
09:15

Induction of Eryptosis in Red Blood Cells Using a Calcium Ionophore

Published on: January 21, 2020

9.5K
Fast and Specific Assessment of the Halogenating Peroxidase Activity in Leukocyte-enriched Blood Samples
05:17

Fast and Specific Assessment of the Halogenating Peroxidase Activity in Leukocyte-enriched Blood Samples

Published on: July 28, 2016

10.7K

Related Experiment Videos

Last Updated: Apr 11, 2026

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
06:29

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells

Published on: January 29, 2014

31.4K
Induction of Eryptosis in Red Blood Cells Using a Calcium Ionophore
09:15

Induction of Eryptosis in Red Blood Cells Using a Calcium Ionophore

Published on: January 21, 2020

9.5K
Fast and Specific Assessment of the Halogenating Peroxidase Activity in Leukocyte-enriched Blood Samples
05:17

Fast and Specific Assessment of the Halogenating Peroxidase Activity in Leukocyte-enriched Blood Samples

Published on: July 28, 2016

10.7K

Area of Science:

  • Hematology
  • Immunology
  • Autoimmune Diseases

Background:

  • Paroxysmal cold hemoglobinuria (PCH) is a rare autoimmune hemolytic anemia.
  • It is characterized by complement-mediated intravascular hemolysis.
  • PCH presents acutely in children post-viral infection and chronically with malignancies or syphilis.

Purpose of the Study:

  • To summarize the key features of paroxysmal cold hemoglobinuria.
  • To highlight the underlying immunological mechanism.
  • To outline current treatment strategies.

Main Methods:

  • Review of existing literature on PCH.
  • Analysis of the immunological basis of PCH.
  • Summary of clinical presentations and treatment outcomes.

Main Results:

  • PCH involves a biphasic antibody targeting the P antigen on red blood cells.
  • The antibody mediates red blood cell lysis upon temperature change.
  • Hemolysis is complement-dependent and intravascular.

Conclusions:

  • PCH is a distinct autoimmune hemolytic anemia with a specific antibody and mechanism.
  • Treatment is primarily supportive, including transfusions.
  • Immunosuppressive therapy may be beneficial in severe or refractory cases.